The redesigned website expands clinical evidence, workflow guidance and access pathways for the Vivio System, an FDA-cleared non-invasive device used to measure elevated left ventricular end-diastolic pressure in outpatient settings. ...
The NMPA acceptance of Chance Pharma’s first new drug application advances CXG87, an improved budesonide/formoterol dry powder inhalation therapy, toward potential commercialisation in China. ...
Jointly developed by SGH, SingHealth and MOHT, LEA-Net uses patient data to identify individuals at higher risk of lower extremity amputation three to five years before foot ulcers and infections develop. ...
Network-wide partnership with Alife Health brings a comprehensive AI platform for fertility care, including CE-marked Embryo Predict, to clinics across 16 countries...
The AI-assisted support feature is designed to help clinicians review CBCT scans more efficiently and clearly when evaluating potential periapical radiolucencies (PARLs)...
Strategic collaboration combines global MedTech development capabilities with specialised ophthalmic expertise to streamline innovation...
Duke-NUS researchers find that pairing a web-based decision-aid with counselling helps elderly patients with end-stage kidney disease and their caregivers make better informed treatment choices – and significantly shifts decisions towards care that prioritises comfort and quality of life....
Late-breaking data demonstrate strong durability and procedural efficiency, reinforcing potential of nanosecond pulsed field ablation in atrial fibrillation treatment...
Focus on real-time data insights and connected monitoring underscores shift toward precision cardiac care and improved clinical decision-making...
Deployment of compact point-of-care brain PET scanners reflects growing demand for earlier, accessible neurodiagnostics in community settings...
